人参的抗疲劳作用:一种治疗长期新冠肺炎的新方法。

Acupuncture and herbal medicine Pub Date : 2022-06-01 Epub Date: 2022-07-08 DOI:10.1097/HM9.0000000000000033
Xiangda Zhou, Keying Zhang, Lanbo Liu, Qianru Zhao, Ming Huang, Rui Shao, Yanyan Wang, Bin Qu, Yu Wang
{"title":"人参的抗疲劳作用:一种治疗长期新冠肺炎的新方法。","authors":"Xiangda Zhou, Keying Zhang, Lanbo Liu, Qianru Zhao, Ming Huang, Rui Shao, Yanyan Wang, Bin Qu, Yu Wang","doi":"10.1097/HM9.0000000000000033","DOIUrl":null,"url":null,"abstract":"<p><p>Two years after the coronavirus disease 2019 (COVID-19) outbreak, an increasing number of patients continue to suffer from long COVID (LC), persistent symptoms, and/or delayed or long-term complications beyond the initial 4 weeks from the onset of symptoms. Constant fatigue is one of the most common LC symptoms, leading to severely reduced quality of life among patients. <i>Ginseng Radix et Rhizoma</i>-known as the King of Herbs in traditional Chinese medicine-has shown clinical anti-fatigue effects. In this review, we summarize the underlying anti-fatigue mechanisms of <i>Ginseng Radix et Rhizoma</i> extracts and their bioactive compounds, with a special focus on anti-viral, immune remodeling, endocrine system regulation, and metabolism, suggesting that <i>Ginseng Radix et Rhizoma</i> is a potentially promising treatment for LC, especially in regard to targeting fatigue.</p>","PeriodicalId":93856,"journal":{"name":"Acupuncture and herbal medicine","volume":"2 2","pages":"69-77"},"PeriodicalIF":0.0000,"publicationDate":"2022-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/c0/ec/hm9-2-69.PMC9407182.pdf","citationCount":"0","resultStr":"{\"title\":\"Anti-fatigue effect from <i>Ginseng Radix et Rhizoma</i>: a suggestive and promising treatment for long COVID.\",\"authors\":\"Xiangda Zhou, Keying Zhang, Lanbo Liu, Qianru Zhao, Ming Huang, Rui Shao, Yanyan Wang, Bin Qu, Yu Wang\",\"doi\":\"10.1097/HM9.0000000000000033\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Two years after the coronavirus disease 2019 (COVID-19) outbreak, an increasing number of patients continue to suffer from long COVID (LC), persistent symptoms, and/or delayed or long-term complications beyond the initial 4 weeks from the onset of symptoms. Constant fatigue is one of the most common LC symptoms, leading to severely reduced quality of life among patients. <i>Ginseng Radix et Rhizoma</i>-known as the King of Herbs in traditional Chinese medicine-has shown clinical anti-fatigue effects. In this review, we summarize the underlying anti-fatigue mechanisms of <i>Ginseng Radix et Rhizoma</i> extracts and their bioactive compounds, with a special focus on anti-viral, immune remodeling, endocrine system regulation, and metabolism, suggesting that <i>Ginseng Radix et Rhizoma</i> is a potentially promising treatment for LC, especially in regard to targeting fatigue.</p>\",\"PeriodicalId\":93856,\"journal\":{\"name\":\"Acupuncture and herbal medicine\",\"volume\":\"2 2\",\"pages\":\"69-77\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/c0/ec/hm9-2-69.PMC9407182.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Acupuncture and herbal medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1097/HM9.0000000000000033\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2022/7/8 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acupuncture and herbal medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/HM9.0000000000000033","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/7/8 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

2019冠状病毒病(新冠肺炎)爆发两年后,越来越多的患者继续遭受长期COVID(LC)、持续症状和/或延迟或长期并发症,超过最初的4 症状出现后数周。持续疲劳是LC最常见的症状之一,导致患者的生活质量严重降低。人参被誉为中药之王,具有良好的临床抗疲劳作用。在这篇综述中,我们总结了人参提取物及其生物活性化合物的潜在抗疲劳机制,特别是抗病毒、免疫重塑、内分泌系统调节和代谢,表明人参是一种潜在的治疗LC的药物,尤其是在靶向疲劳方面。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Anti-fatigue effect from <i>Ginseng Radix et Rhizoma</i>: a suggestive and promising treatment for long COVID.

Anti-fatigue effect from <i>Ginseng Radix et Rhizoma</i>: a suggestive and promising treatment for long COVID.

Anti-fatigue effect from <i>Ginseng Radix et Rhizoma</i>: a suggestive and promising treatment for long COVID.

Anti-fatigue effect from Ginseng Radix et Rhizoma: a suggestive and promising treatment for long COVID.

Two years after the coronavirus disease 2019 (COVID-19) outbreak, an increasing number of patients continue to suffer from long COVID (LC), persistent symptoms, and/or delayed or long-term complications beyond the initial 4 weeks from the onset of symptoms. Constant fatigue is one of the most common LC symptoms, leading to severely reduced quality of life among patients. Ginseng Radix et Rhizoma-known as the King of Herbs in traditional Chinese medicine-has shown clinical anti-fatigue effects. In this review, we summarize the underlying anti-fatigue mechanisms of Ginseng Radix et Rhizoma extracts and their bioactive compounds, with a special focus on anti-viral, immune remodeling, endocrine system regulation, and metabolism, suggesting that Ginseng Radix et Rhizoma is a potentially promising treatment for LC, especially in regard to targeting fatigue.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信